Payment overview · 2025
General Payments
$8,959.68
107 reported records · 22 companies
Healthcare provider profile · identity verified
Shane Mcentire, M.D.
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · TALLAHASSEE, FL · NPI 1932224912
Verified facts
What the public records show
CMS Open Payments records show Shane Mcentire, M.D. received $8,959.68 in general payments during 2025 across 107 reported records.
Penumbra, Inc. accounted for 41.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 41 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $3,707.35 | 41.4% | 33 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $1,682.89 | 18.8% | 8 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $589.97 | 6.6% | 7 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $571.75 | 6.4% | 4 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $563.50 | 6.3% | 20 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $436.02 | 4.9% | 2 | 2025 |
| CVRx, Inc. | Unresolved — no canonical attribution shown | $360.67 | 4.0% | 4 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $215.71 | 2.4% | 5 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $149.55 | 1.7% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $144.56 | 1.6% | 3 | 2025 |
| Veryan Medical Incorporated | Unresolved — no canonical attribution shown | $123.05 | 1.4% | 1 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $58.04 | 0.7% | 1 | 2025 |
| Solventum Corporation | Unresolved — no canonical attribution shown | $55.30 | 0.6% | 2 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $55.10 | 0.6% | 3 | 2025 |
| ETS Wound Care LLC | Unresolved — no canonical attribution shown | $50.24 | 0.6% | 2 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $48.46 | 0.5% | 3 | 2025 |
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $34.00 | 0.4% | 2 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $29.61 | 0.3% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $24.23 | 0.3% | 1 | 2025 |
| Ethicon US, LLC | Unresolved — no canonical attribution shown | $20.96 | 0.2% | 1 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $19.40 | 0.2% | 1 | 2025 |
| Urgo Medical North America, LLC | Unresolved — no canonical attribution shown | $19.32 | 0.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $5,627.28 | 102 |
| Travel and Lodging | $3,332.40 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $3,516.13 | 31 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $627.92 | 7 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $589.97 | 7 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $571.75 | 4 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $436.02 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $436.02 | 2 | 2025 |
Source payment records
|
|||||
| Barostim Neo System Normalized: barostim neo system |
Device | CVRx, Inc. | $360.67 | 4 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $192.35 | 9 | 2025 |
Source payment records
|
|||||
| RUBY Coil Normalized: ruby coil |
Device | Penumbra, Inc. | $191.22 | 2 | 2025 |
Source payment records
|
|||||
| ARTEGRAFT VASCULAR GRAFT Normalized: artegraft vascular graft |
Device | LeMaitre Vascular, Inc. | $149.55 | 2 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $144.56 | 3 | 2025 |
Source payment records
|
|||||
| LIMFLOW SYSTEM Normalized: limflow system |
Device | Stryker Corporation | $139.58 | 1 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $133.00 | 3 | 2025 |
Source payment records
|
|||||
| General - Angioplasty Normalized: general angioplasty |
Device | Boston Scientific Corporation | $127.83 | 1 | 2025 |
Source payment records
|
|||||
| BioMimics 3D Vascular Stent System Normalized: biomimics 3d vascular stent system |
Device | Veryan Medical Incorporated | $123.05 | 1 | 2025 |
Source payment records
|
|||||
| PREVENA Normalized: prevena |
Device | Solventum Corporation | $55.30 | 2 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $55.10 | 3 | 2025 |
Source payment records
|
|||||
| MIRRAGEN ADVANCED WOUND MATRIX Normalized: mirragen advanced wound matrix |
Device | ETS Wound Care LLC | $50.24 | 2 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $48.46 | 3 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $48.46 | 3 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $45.38 | 2 | 2025 |
Source payment records
|
|||||
| ARTIX MT Normalized: artix mt |
Device | Stryker Corporation | $39.65 | 2 | 2025 |
Source payment records
|
|||||
| Innova Vascular Normalized: innova vascular |
Device | Boston Scientific Corporation | $38.12 | 2 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $36.48 | 2 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $29.61 | 1 | 2025 |
Source payment records
|
|||||
| ANGIO-SEAL Normalized: angio seal |
Device | Terumo Medical Corporation | $24.23 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $24.23 | 1 | 2025 |
Source payment records
|
|||||
| ETHICON Normalized: ethicon |
Device | Ethicon US, LLC | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| PROLENE Normalized: prolene |
Device | Ethicon US, LLC | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| SURGICEL NU-KNIT Normalized: surgicel nu knit |
Device | Ethicon US, LLC | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| VISTASEAL Normalized: vistaseal |
Biological | Ethicon US, LLC | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $19.40 | 1 | 2025 |
Source payment records
|
|||||
| VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP Normalized: vashe wound solution 250 ml 8 5 fl oz flip top cap |
Device | Urgo Medical North America, LLC | $19.32 | 1 | 2025 |
Source payment records
|
|||||
| 2cm Peripheral Cutting Balloon Normalized: 2cm peripheral cutting balloon |
Device | Boston Scientific Corporation | $17.69 | 1 | 2025 |
Source payment records
|
|||||
| Ranger Normalized: ranger |
Device | Boston Scientific Corporation | $17.43 | 1 | 2025 |
Source payment records
|
|||||
| PRODIGY CATHETER Normalized: prodigy catheter |
Device | Imperative Care, Inc | $17.00 | 1 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $17.00 | 1 | 2025 |
Source payment records
|
|||||
| V.A.C. VERAFLO CLEANSE CHOICE Normalized: v a c veraflo cleanse choice |
Device | Solventum Corporation | $15.91 | 1 | 2025 |
Source payment records
|
|||||
| Express LD Iliac / Biliary Normalized: express ld iliac biliary |
Device | Boston Scientific Corporation | $14.98 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $11.54 | 1 | 2025 |
Source payment records
|
|||||
| General - Guidewires Normalized: general guidewires |
Device | Boston Scientific Corporation | $10.56 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $8,959.68 · 107 records | Penumbra, Inc. | 2cm Peripheral Cutting Balloon, ANGIO-SEAL, ARTEGRAFT VASCULAR GRAFT, ARTIX MT, AZUR CX DETACHABLE, Barostim Neo System, BioMimics 3D Vascular Stent System, CGuard Prime Carotid Stent System, CLOTTRIEVER BOLD CATHETER, COLLAGENASE SANTYL, ELUVIA, ENROUTE Transcarotid Neuroprotection System, ESPRIT, ETHICON, Express LD Iliac / Biliary, Flexitouch Plus, General - Angioplasty, General - Guidewires, General - Vascular Intervention, Indigo System, Innova Vascular, Kerecis GraftGuide, Kerecis SurgiClose, LIMFLOW SYSTEM, MIRRAGEN ADVANCED WOUND MATRIX, Nimbl, PREVENA, PRODIGY CATHETER, PROLENE, Pounce Thrombectomy, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, RUBY Coil, Ranger, SURGICEL NU-KNIT, SYMPHONY CATHETER, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TREO ABDOMINAL STENT-GRAFT SYSTEM, V.A.C. VERAFLO CLEANSE CHOICE, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, VISTASEAL | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error